课题基金 / 基金详情

Development of a cytotoxic T-lymphocyte based cell-to-cell therapeutic delivery system

Development of a cytotoxic T-lymphocyte based cell-to-cell therapeutic delivery system
开发基于细胞毒性 T 淋巴细胞的细胞间治疗递送系统
批准号：
283870
负责人：
Woodsworth Daniel J
金额：
$7.65万
依托单位：
B.C. Cancer Research Centre (Vancouver)
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2012
资助国家：
加拿大
项目状态：
已结题
起止时间：
2012-10-01 至 2015-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=283870&lang=en
关键词：
Adoptive Cell Therapy Experimental Therapeutics Fusion Proteins Genetic Engineering Granzymes Rna Interference Synthetic Biology T Lymphocytes

项目摘要

项目成果

Woodsworth Daniel J的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
One of the main issues with all pharmaceutical therapy is unwanted side effects. Not only are these adverse effects extremely unpleasant and even at times life threatening, but concerns over adverse outcomes often limit the utility of a given therapeutic.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a Lymphocyte based Cell-to-Cell Therapeutic Delivery System
Development of Phage Activated Bacterial Cancer Therapeutics for Colorectal Cancer.
  • 批准号：
    255327
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $1.27万
  • 财政年份：
    2012
  • 负责人：
    Woodsworth Daniel J
  • 依托单位：
    BC Cancer, part of PHSA (Vancouver)
海外基金